Targeting the p53 cancer mutants Y220C, Y220N, and Y220S with the small-molecule stabilizer rezatapopt.
- DOI
- 10.1038/s41419-026-08492-9
- Published
- 2026 Feb 26
- Container
- Cell death & disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-026-08492-9,
title = {Targeting the p53 cancer mutants Y220C, Y220N, and Y220S with the small-molecule stabilizer rezatapopt.},
author = {Mavridi D and Funk JS and Balourdas DI and Krämer A and Khan Tareque R and Timofeev O and Spencer J and Stiewe T and Joerger AC},
year = {2026},
journal = {Cell death \& disease},
doi = {10.1038/s41419-026-08492-9},
url = {https://doi.org/10.1038/s41419-026-08492-9}
}RIS
TY - JOUR TI - Targeting the p53 cancer mutants Y220C, Y220N, and Y220S with the small-molecule stabilizer rezatapopt. AU - Mavridi D AU - Funk JS AU - Balourdas DI AU - Krämer A AU - Khan Tareque R AU - Timofeev O AU - Spencer J AU - Stiewe T AU - Joerger AC PY - 2026 JO - Cell death & disease DO - 10.1038/s41419-026-08492-9 UR - https://doi.org/10.1038/s41419-026-08492-9 ER -
APA
D, M., JS, F., DI, B., A, K., R, K. T., O, T., J, S., T, S., & AC, J. (2026). Targeting the p53 cancer mutants Y220C, Y220N, and Y220S with the small-molecule stabilizer rezatapopt.. Cell death & disease. https://doi.org/10.1038/s41419-026-08492-9
Source records
- pubmed · retrieved 2026-09-26T02:26:41.104Z